Evaluation of extended-field radiotherapy for prostatic neoplasm: 1976 progress report.
These observations show that short-term, disease-free survival is (a) excellent (86.5%) in patients with negative lymph node biopsies, (b) greatly diminished (30%) in patients with positive para-aortic and pelvic lymph node biopsies, and (c) intermediate (71.5%) in patients with positive pelvic lymph node biopsies only in the pelvic region following extended-field radiation therapy of carcinoma of the prostate.
D001706:Biopsy; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology; D008207:Lymphatic Metastasis; D008297:Male; D008722:Methods; D011471:Prostatic Neoplasms / Q000473:pathology / Q000532:radiotherapy*